Delivery Order SPE2DB20D1100-SPE2DB24FC4L6

Award Date 6/26/24
Potential Completion Date 6/27/24
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D1100|SPE2DB25FZ43D, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Carvedilol ER 40 mg capsules and has a ceiling value of $2,986.77. It is a firm fixed-price delivery order contract with a completion date of December 9, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This federal contract award, with ID SPE2DB22D1017|SPE2DB24FE9WR, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of Carvedilol ER 40 mg capsules in 30-count packages, with a total ceiling value of $1,027.79 and an ultimate completion date of December 15, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $20,426.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $2,464.39, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a cardiovascular medication, to support military healthcare programs. The contract is a firm fixed-price delivery order with a completion date of March 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB24FP48B, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $25,415.92 firm fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules, a cardiovascular medication. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,803.91 firm-fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules, a medication used to treat cardiovascular conditions. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award, with an ID of SPE2DB22D1017|SPE2DB25FF3KK, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4566964371 Carvedilol ER 40 mg capsules, a pharmaceutical product used for cardiovascular health. The contract has a ceiling value of $4,576.56 and is a Firm Fixed Price Delivery Order, with a completion date of January 17, 2025. The contract was awarded on January 16, 2025, and there...
This federal contract award, valued at $6,126.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Carvedilol ER 40 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of October 25, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has established itself as a key vendor for federal healthcare programs,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,911.53 firm-fixed-price delivery order is for the supply of Carvedilol ER 40 mg capsules, a cardiovascular medication, to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $2,796.40, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Carvedilol ER 10 mg capsules and has an ultimate completion date of November 21, 2024. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and it does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a for-profit...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC4L6
    Delivery Order

This federal contract award, identified as SPE2DB20D1100|SPE2DB24FC4L6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 40 mg capsules, a cardiovascular medication, to support military healthcare programs.

The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,662.78, and has an ultimate completion date of June 27, 2024. It is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization registered in the System for Award Management (SAM.gov) since 2002 and specializes in distributing a wide range of pharmaceutical products and medical supplies to federal agencies, particularly the DLA Troop Support Medical.

The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen Drug Corp with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/17/25, 9:58 AM